MDCorp (MDCX) P/B (2016 - 2026)
MDCorp (MDCX) P/B from Feb 3, 2016 to Jun 3, 2026. The TTM MDCorp (MDCX) P/B is 10.75. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of MDCorp (MDCX)
| Year | P/B | Change |
|---|---|---|
| 2026 | 10.75 | -101.95% |
| 2025 | -550.28 | -6098.28% |
| 2024 | 9.17 | +535.56% |
| 2018 | 1.44 | +616.42% |
| 2017 | 0.20 | +346.67% |
| 2016 | 0.05 | N/A |
Comparison MDCorp (MDCX) P/B with competitors
MDCorp (MDCX) P/B is 10.75.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.67 | -93.80% |
| GRFS | Grifols SA | 0.86 | -91.98% |
| SNY | Sanofi | 1.25 | -88.36% |
| BIIB | Biogen Inc | 1.55 | -85.55% |
| PFE | Pfizer Inc | 1.66 | -84.58% |
| OGN | Organon & Company | 3.88 | -63.90% |
| GSK | GSK Plc | 4.30 | -60.05% |
| MIRA | Mira Pharmaceuticals Inc | 4.90 | -54.44% |
| BMY | Bristol-Myers Squibb Company | 5.91 | -45.04% |
| AZN | Astrazeneca plc | 6.07 | -43.55% |
| NVO | Novo Nordisk | 6.24 | -41.97% |
| MRK | Merck & Co Inc | 6.47 | -39.83% |
| JNJ | Johnson & Johnson | 6.86 | -36.21% |
| GILD | Gilead Sciences Inc | 7.06 | -34.35% |
| NVS | Novartis AG | 7.49 | -30.35% |
| NSRX | Nasus Pharma Ltd | 14.22 | +32.23% |
| AMGN | AMGEN Inc | 19.74 | +83.57% |
| SCLX | Scilex Holding Company | 28.85 | +168.28% |
| LLY | Lilly(Eli) & Company | 30.95 | +187.81% |
| ABBV | Abbvie Inc | 50.46 | +369.24% |